REGENXBIO Inc.
RGNX
$9.66
$0.293.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -196.43M | -290.01M | -193.88M | -177.92M | -175.57M |
| Total Depreciation and Amortization | 15.37M | 15.52M | 15.62M | 15.77M | 15.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.34M | 46.85M | 42.52M | 33.61M | 30.17M |
| Change in Net Operating Assets | -116.95M | -6.13M | 11.78M | 25.24M | 41.68M |
| Cash from Operations | -246.67M | -233.78M | -123.96M | -103.30M | -87.89M |
| Capital Expenditure | -2.99M | -2.63M | -2.41M | -2.99M | -2.82M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 219.33M | 12.60M | -13.45M | -10.15M | -2.34M |
| Cash from Investing | 216.34M | 9.98M | -15.87M | -13.13M | -5.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 21.18M | 1.70M | 1.37M | 1.31M | 1.47M |
| Repurchase of Common Stock | -951.00K | -951.00K | -633.00K | -633.00K | -510.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.96M | 108.17M | 116.04M | 117.93M | 113.89M |
| Cash from Financing | -12.74M | 108.93M | 116.77M | 118.62M | 114.84M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.07M | -114.88M | -23.06M | 2.19M | 21.79M |